CNBC’s Jim Cramer said Moderna’s expanding pipeline in treatments for cancer and other diseases provides a compelling long-term investment thesis.
Jim Cramer says this former Covid market darling is finally investable again
No Comments0 Views
Trending
- Iconic seafood chain files lawsuit after bankruptcy
- Walmart is selling a storage shed with lockable doors for only $95
- Goldman Sachs delivers honest verdict on gold’s selloff
- Kroger just shook up the supermarket landscape
- Citadel’s hedge funds post broad first-half gains, top performing strategy sidesteps quant selloff
- Google Ventures makes surprise $30 million SpaceX-era bet
- Bose wireless speakers offer top-notch audio starting at $79
- Walmart’s bestselling $151 nightstand set is 53% off
